Blog Posts in 2010
Posted on Sep 15, 2010 By DeCarli Law
An expert panel announced yesterday that long-term use of Fosamax and other osteoporosis drugs may be related to serious fractures of the thigh bone. Fosamax is one of a class of drugs called ...
Continue reading "Experts Recognize Possible Link Between Thigh-Bone Fractures and Long-Term Fosamax Use" »
Posted on Sep 13, 2010 By DeCarli Law
The FDA recently ordered the recall of diet drug Solo Slim because it contains an undeclared drug ingredient, Didesmethyl Sibutramine, a risk for people with a history of heart disease. However, Solo ...
Continue reading "Recalled Diet Drug Solo Slim Contains Synephrine" »
Posted on Sep 9, 2010 By DeCarli Law
The U.S. Food and Drug Administration (FDA) announced today that it will require significant label changes for gadolinium-based contrast agents (GBCAs) in order to reduce the risk of nephrogenic ...
Continue reading "FDA Orders Label Changes for Gadolinium-Based Contrast Agents" »
Posted on Sep 9, 2010 By DeCarli Law
Bad news for women’s health: yet another generic form of the oral contraceptive Yasmin will be sold in the United States. Watson Pharmaceuticals, Inc. announced on Tuesday that it has received ...
Continue reading "Zarah, a New Generic Form of Yasmin, to Be Sold in the U.S." »
Posted on Aug 17, 2010 By DeCarli Law
The Financial Times reported on Thursday that the United States Department of Justice is conducting a corruption probe of several major pharmaceutical companies, including GlaxoSmithKline, Pfizer, ...
Continue reading "Justice Department Investigating Pharmaceutical Companies for Violation of U.S. Anti-Bribery Laws" »
Posted on Aug 13, 2010 By DeCarli Law
The FDA has issued a safety alert disclosing that Lamictal (lamotrigine) can cause aseptic meningitis. Lamictal (lamotrigine) is a medication commonly used to treat seizures in children two years and ...
Continue reading "FDA Orders Label Change for Lamictal (lamotrigine) to Disclose Risk of Aseptic Meningitis" »
Posted on Aug 13, 2010 By DeCarli Law
The Food and Drug Administration (FDA) today ordered the recall of the male enhancement supplement Prolactis because it contains an undeclared drug ingredient. Lab analysis has found that Prolactis ...
Continue reading "Prolactis, an Over-the-Counter Male Enhancement Supplement, Recalled Today for Containing Undeclared Drug Ingredient" »
Posted on Aug 12, 2010 By DeCarli Law
The FDA has just accepted Bayer Schering Pharma's New Drug Application for Gadovist, a gadolinium-based contrast agent currently sold in Europe and other parts of the world, but not in the United ...
Continue reading "After Years of Delay, Bayer Asks the FDA for Approval of Gadovist, its Safer Gadolinium-Based Contrast Long Available in Europe" »
Posted on Aug 9, 2010 By DeCarli Law
The FDA announced today the recall of appetite suppressants “Solo Slim” and “Solo Slim Extra Strength.” FDA lab analysis revealed that Solo Slim contains an undeclared drug ingredient, Didesmethyl ...
Continue reading "Recall of Appetite Suppressant “Solo Slim”" »
Posted on Aug 2, 2010 By DeCarli Law
DeCarli Law is no longer taking new clients injured by Fleet Phospho-Soda or Fleet Phospho soda EZ Prep Bowel Cleansing System. However, DeCarli Law will continue to investigate claims for kidney ...
Continue reading "DeCarli Law No Longer Accepting Fleet Cases" »
Posted on Jun 21, 2010 By DeCarli Law
Another favorable ruling was issued in the federal multi-district litigation (MDL), where the claims of some people suffering from nephrogenic systemic fibrosis (NSF) are being adjudicated. On Friday, ...
Continue reading "Federal Judge in NSF Litigation Stands By Previous Order on Expert Testimony" »
Posted on Jun 8, 2010 By DeCarli Law
The Cleveland Plain Dealer has reported that C.B. Fleet Co. is "close to reaching a final settlement" with people across the country who say their kidneys were harmed by Fleet's over-the-counter ...
Continue reading "The Cleveland Plain Dealer Reports Fleet Settlement Coming Soon" »
Posted on May 11, 2010 By DeCarli Law
Today, the U.S. Food and Drug Administration announced the launch of what it calls the “Bad Ad Program.” The program is designed to educate health care providers about their role in ensuring that ...
Continue reading "FDA Announces “Bad Ad Program” to Help Health Care Providers Detect and Report Misleading Drug Ads" »
Posted on May 10, 2010 By DeCarli Law
A recent court ruling has strengthened the legal position in federal court of those suffering from Nephrogenic Systemic Fibrosis (NSF) . A federal judge rejected the arguments of defendant GE ...
Continue reading "Federal Judge Rejects GE Healthcare Arguments to Exclude Expert Testimony on Cause of NSF" »
Posted on Apr 27, 2010 By DeCarli Law
Important news for Californians suffering from nephrogenic systemic fibrosis (NSF) : California NSF lawsuits have been consolidated in Department 304 of the San Francisco Superior Court, with the ...
Continue reading "California NSF Cases Are Consolidated in San Francisco Superior Court" »
Posted on Apr 9, 2010 By DeCarli Law
The Associated Press is reporting that Bayer HealthCare, "[i]n cooperation with the Food and Drug Administration," has added new warnings about the risk of blood clots that come with using YAZ and ...
Continue reading "New Warning of Blood Clot Risk for YAZ and Yasmin" »
Posted on Feb 9, 2010 By DeCarli Law
The immunosuppressant drug rapamycin , also known as sirolimus , may help improve the symptoms of nephrogenic systemic fibrosis (NSF) , according to a Case Report published in the February 2010 ...
Continue reading "Rapamycin a Possible Treatment for Nephrogenic Systemic Fibrosis (NSF)" »
Posted on Jan 8, 2010 By DeCarli Law
If you began having serious kidney problems just weeks after a colonoscopy, the cause may have been the Fleet Phospho-Soda or Fleet Phospho soda EZ Prep Bowel Cleansing System you used before your ...
Continue reading "Dialysis or Kidney Transplant After Colonoscopy" »
Posted on Jan 8, 2010 By DeCarli Law
A recent decision from the 8th Circuit Court of Appeals has removed a barrier to women filing lawsuits for side effects from Ocella birth control. Ocella is the generic version of the oral ...
Continue reading "8th Circuit Removes Roadblock for Ocella Injury Lawsuits" »
Posted on Jan 6, 2010 By DeCarli Law
A paper presented at the recent annual convention of the American Society of Hematology reported that exposure to the gadolinium-based contrast agent Omniscan , manufactured by GE Healthcare, speeds ...
Continue reading "Gadolinium-Based Contrast Agents Speed Multiple Myeloma Cell Growth" »